Oral capecitabine in anthracycline- and taxane-pretreated advanced/metastatic breast cancer

Author： Wist Erik   Sommer Hilde   Østenstad Bjørn   Risberg Terje   Bremnes Yngve   Mjaaland Ingvild  

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.43, Iss.2, 2004-03, pp. : 186-189

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Capecitabine monotherapy in patients with anthracycline-and taxane-pretreated metastatic breast cancer

By Lee S.-H.   Lee J.   Park J.   Park S.   Lee K.-E.   Lee S.   Nam E.   Park J.   Kim K.   Jung C.   Park Y.   Yoon S.   Kang W.   Lee M.   Park K.   Im Y.-H.  

Medical Oncology, Vol. 21, Iss. 3, 2004-09 ,pp. : 223-231

Humana Press, Inc

Access to resources Recommend Favorite

Vinorelbine and capecitabine in anthracycline- and/or taxane-pretreated metastatic breast cancer: sequential or combinational?

By Zhang Jian   Gu Shi-Yang   Gan Yu   Wang Zhong-Hua   Wang Bi-Yun   Guo Hai-Yi   Wang Jia-Lei   Wang Lei-Ping   Zhao Xin-Min   Hu Xi-Chun  

Cancer Chemotherapy and Pharmacology, Vol. 71, Iss. 1, 2013-01 ,pp. : 103-113

Springer Publishing Company

Access to resources Recommend Favorite

A randomized phase II non-comparative study of pemetrexedcarboplatin and gemcitabinevinorelbine in anthracycline- and taxane-pretreated advanced breast cancer patients

By                    

International Journal of Oncology, Vol. 42, Iss. 5, 2013-01 ,pp. : 1778-1785

Spandidos Publications

Access to resources Recommend Favorite

A multicentre phase II study on gefitinib in taxane- and anthracycline-pretreated metastatic breast cancer

By Minckwitz Gunter   Jonat Walter   Fasching Peter   Bois Andreas   Kleeberg Ulrich   Lück Hans-Joachim   Kettner Erika   Hilfrich Jörn   Eiermann Wolfgang   Torode Julie   Schneeweiss Andreas  

Breast Cancer Research and Treatment, Vol. 89, Iss. 2, 2005-01 ,pp. : 165-172

Springer Publishing Company

Access to resources Recommend Favorite

Phase II, double-blind, randomized trial of capecitabine plus enzastaurin versus capecitabine plus placebo in patients with metastatic or recurrent breast cancer after prior anthracycline and taxane therapy

By Clemons Mark   Joy Anil   Abdulnabi Radhi   Kotliar Mauricio   Lynch Jodi   Jordaan Johan   Iscoe Neill   Gelmon Karen  

Breast Cancer Research and Treatment, Vol. 124, Iss. 1, 2010-11 ,pp. : 177-186

Springer Publishing Company

Access to resources Recommend Favorite